More than 200 coronavirus vaccines are still in development as the initial vaccine rollout ramps up. Here's how experts anticipate 2021 playing out.

6:05am PST - January 23rd, 2021    novavax stock - Business Insider

Summary List PlacementAs the first coronavirus vaccines are rolling out, the 200-plus additional candidates in development face immense challenges in ever reaching the public. Despite the uncertainty, investor enthusiasm has remained. The vaccine ambitions of…